Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.

Received from

Pending at the end of last month

Received

Resolved*

Total Pending #

Pending complaints >3months

Average Resolution time^ (in days)

Directly from Investors

SEBI (SCORES)

Other Sources (if any)

Grand Total

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.

Month

Carried forward from previous month

Received

Resolved*

Pending#

Jun, 2026

Jul, 2026

Aug, 2026

Grand Total

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Sr. No.

Fin. Year

Carried forward from previous year

Received

Resolved*

Pending#

2022-23

2023-24

2024-25

2025-26

Grand Total

Top Pharma Companies in India by Market Cap

BSE Sensex 71924.68 547.65 (-0.76%)

Filter

Top Pharma Companies in India as on Oct-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
121	3B Blackbio Dx Ltd.	Q V PT	1,352 Small Cap	1,612.40 (2.33%)	24.92	4.15	-8.95	-14.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
122	Kopran Ltd.	Q V+ PT	1,214 Small Cap	261.70 (4.14%)	50.62	2.36	6.74	-8.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
123	GPT Healthcare Ltd.	Q V PT	1,149 Small Cap	143.40 (2.43%)	24.89	4.17	14.25	6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
124	Bajaj Healthcare Ltd.	Q V PT	1,076 Small Cap	330.60 (3.44%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
125	Lincoln Pharmaceuticals Ltd.	Q V PT	1,119 Small Cap	544.25 (-2.55%)	11.3	1.37	9.61	3.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
126	Sigachi Industries Ltd.	Q V+ PT	1,090 Small Cap	28.38 (-0.49%)	42.77	2.05	19.91	-146.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
127	Laxmi Dental Ltd.	Q V PT	1,075 Small Cap	196.30 (0.51%)	34.97	4.4	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
128	One Global Service Provider Ltd.	Q V+ PT	1,107 Small Cap	548.40 (-3.21%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
129	Themis Medicare Ltd.	Q V PT	1,004 Small Cap	108.25 (-0.73%)	24.94	2.37	8.21	-69.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
130	Kilitch Drugs (India) Ltd.	Q V+ PT	849 Small Cap	238.70 (-1.65%)	27.77	2.97	28.00	58.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
131	Anuh Pharma Ltd.	Q V PT	818 Small Cap	81.27 (-0.37%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
132	Gaudium IVF and Women Health Ltd.	Q V PT	770 Small Cap	105.30 (-0.47%)	31.33	4.97	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
133	Wanbury Ltd.	Q V+ PT	685 Small Cap	191.95 (-1.99%)	15.62	10	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
134	Fabtech Technologies Ltd.	Q V PT	591 Small Cap	131.40 (-1.17%)	11.99	1.38	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
135	Medicamen Biotech Ltd.	Q V+ PT	414 Small Cap	304.25 (-0.36%)	38.11	1.52	5.31	-13.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
136	Ambalal Sarabhai Enterprises Ltd.	Q V PT	309 Small Cap	39.02 (-3.15%)	22.06	1.85	4.33	3.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
137	Gennex Laboratories Ltd.	Q V PT	233 Small Cap	9.58 (-0.31%)	12	1.02	19.91	45.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
138	Take Ltd.	Q V PT	199 Small Cap	12.75 (-4.99%)	14.71	5.88	-41.25	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
139	Medico Remedies Ltd.	Q V+ PT	189 Small Cap	22.08 (-2.86%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Syngene Internatl.	371.75	7.04%
RPG Life Sciences	2,859.35	5.10%
Anlon Healthcare	29.61	5%
Bliss GVS Pharma	672.75	4.38%
Kopran	261.70	4.14%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Park Medi World	254.65	-5.95%
Take	12.75	-4.99%
KMC Speciality Hosp.	161.15	-4.90%
Fortis Healthcare	757.50	-3.52%
Manipal Health Enter	678.55	-3.22%

News about Top Pharma Companies in India

Oct, 2026

Wanbury's arm launches ‘berrysoft’ baby product range across multiple states in India

The berrysoft baby range has been developed to address everyday baby skincare and hygiene needs

Oct, 2026

Bajaj Healthcare informs about compliances-certificate

Bajaj Healthcare has attached certificate received from MUFG Intime India (formerly known as Link Intime India), Registrar and Share Transfer Agent of the Company under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Kopran informs about disclosure

Kopran has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sarvamangal Mercantile Company.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Gaudium IVF starts operations at new IVF Centre in Haryana

The Centre/Hub is designed to provide comprehensive fertility and reproductive healthcare services under one roof

Sep, 2026

Fabtech Technologies informs about investor meeting

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fabtech Technologies has informed that the management of the Company will be interacting with the Investors/ Analysts on 29th September, 2026 between 04:00 pm to 05:00 pm in Mumbai through its Investor Relations firm, Kaptify Consulting. During the aforesaid Investors/Analyst(s) meet, no unpublished price sensitive information is intended to be discussed. The Discussions with the Investors/Analyst(s) would be based on publicly available information. The meeting may be cancelled, rescheduled, or postponed due to unavoidable exigencies.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Gennex Laboratories informs about closure of trading window

In pursuance of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, Gennex Laboratories has informed that the Trading Window for dealing in the securities of the Company shall remain closed from October 01, 2026 till 48 hours after the public announcement through Board of Directors in their Meeting held for announcing the Unaudited Standalone and Consolidated Financial Results for the Second Quarter and Half year ended on September 30, 2026 along with other matters for which trading window is required to be closed. The Board Meeting date to approve the Un-audited Standalone and Consolidated financial results of the Company for the Second Quarter and Half year ended on September 30, 2026 will be informed in due course. All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sun Pharmaceutical Industries Ltd.	4,21,539 Crore
2	Divis Laboratories Ltd.	2,47,576 Crore
3	Torrent Pharmaceuticals Ltd.	1,77,251 Crore
4	Zydus Lifesciences Ltd.	1,11,232 Crore
5	Apollo Hospitals Enterprise Ltd.	1,15,315 Crore
6	Laurus Labs Ltd.	1,09,797 Crore
7	Cipla Ltd.	1,05,290 Crore
8	Dr. Reddys Laboratories Ltd.	99,753 Crore
9	Mankind Pharma Ltd.	97,850 Crore
10	Aurobindo Pharma Ltd.	97,014 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,800	55,248	34.22	10.67	23.45	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,679	1,77,251	81.27	19.75	37.27	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,282	64,665	35.97	5.90	11.99	27.89
Lupin Ltd. (M)	Somewhat Good	1,946	89,629	16.21	3.77	8.98	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,398	42,624	37.56	8.77	25.38	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,071	1,09,797	136
Sai Life Sciences Ltd. (S)	Somewhat Good	1,470	31,613	71.13
Gland Pharma Ltd. (M)	Very Good	3,079	50,528	60.23
Aurobindo Pharma Ltd. (M)	Very Good	1,703	97,014	50.61
Divis Laboratories Ltd. (L)	Very Good	9,379	2,47,576	44.78
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,470	31,613	87.39	12.38	45.07	23.61
Mankind Pharma Ltd. (M)	Very Good	2,399	97,850	47.90	5.82	24.91	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,398	42,624	37.56	8.77	25.38	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,139	1,11,232	24.65	4.13	13.85	13.52
Gland Pharma Ltd. (M)	Very Good	3,079	50,528	44.76	4.75	22.89	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,470	31,613	87.39	12.38	45.07	39.96
Lupin Ltd. (M)	Somewhat Good	1,946	89,629	16.21	3.77	8.98	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,282	64,665	35.97	5.90	11.99	22.19
Abbott India Ltd. (M)	Very Good	25,800	55,248	34.22	10.67	23.45	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,231	99,753	30.96	2.61	15.87	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

^ Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Wanbury's arm launches ‘berrysoft’ baby product range across multiple states in India

Bajaj Healthcare informs about compliances-certificate

Kopran informs about disclosure

Gaudium IVF starts operations at new IVF Centre in Haryana

Fabtech Technologies informs about investor meeting

Gennex Laboratories informs about closure of trading window

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?